295 related articles for article (PubMed ID: 9924474)
41. Gonococcal Conjunctivitis Despite Successful Treatment of Male Urethritis Syndrome.
Peters RP; Verweij SP; McIntyre JA; Schaftenaar E
Sex Transm Dis; 2016 Feb; 43(2):120-1. PubMed ID: 26760182
[TBL] [Abstract][Full Text] [Related]
42. In vitro activity of several antimicrobial agents against Neisseria gonorrhoeae in the western region of the Kingdom of Saudi Arabia.
Raddadi AA; Zimmo SK; Abdullah SA
Sex Transm Infect; 1998 Aug; 74(4):294. PubMed ID: 9924473
[No Abstract] [Full Text] [Related]
43. Antimicrobial resistance patterns in
Nacht C; Agingu W; Otieno F; Odhiambo F; Mehta SD
Int J STD AIDS; 2020 Jan; 31(1):46-52. PubMed ID: 31870236
[No Abstract] [Full Text] [Related]
44. [Clinico-epidemiological and microbiological studies of the causes of recurrences in gonorrhea].
Skuratovich AA; Potapnev FV; Bednova VN; Danilova TN; Andriasian SG
Vestn Dermatol Venerol; 1982 May; (5):29-32. PubMed ID: 6810575
[No Abstract] [Full Text] [Related]
45. [Clinico-epidemiological features and antimicrobial resistance pattern in gonococcal infection].
Bădescu AC; Duca E; Brănişteanu DE; Dobre C; Solovăstru LG; Stătescu L; Stoleru G; Vasîlca A; Vâţă D; Petrescu Z
Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1237-42. PubMed ID: 22276476
[TBL] [Abstract][Full Text] [Related]
46. [Male urethritis].
Gerhardt P; Dupin N; Janier M; Lassau F; Passeron A; Milpied B;
Ann Dermatol Venereol; 2016 Nov; 143(11):752-755. PubMed ID: 27776813
[No Abstract] [Full Text] [Related]
47. Cefuroxime treatment of urethritis caused by a beta-lactamase-producing strain of Neisseria gonorrhoeae.
Normark S; Elmros T; Norlander L; Kjellberg E; Holm S; Burman LA; Bergström S
Acta Derm Venereol; 1980; 60(3):277-9. PubMed ID: 6158239
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
Hovhannisyan G; von Schoen-Angerer T; Babayan K; Fenichiu O; Gaboulaud V
Sex Transm Dis; 2007 Sep; 34(9):686-8. PubMed ID: 17621247
[TBL] [Abstract][Full Text] [Related]
49. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval.
Deguchi T; Yasuda M; Yokoi S; Ishida K; Ito M; Ishihara S; Minamidate K; Harada Y; Tei K; Kojima K; Tamaki M; Maeda S
J Infect Chemother; 2003 Mar; 9(1):35-9. PubMed ID: 12673405
[TBL] [Abstract][Full Text] [Related]
50. Infections with non-penicillinase-producing Neisseria gonorrhoeae treated with cefuroxime: treatment failures.
de Hoop D; Nayyar KC; van Klingeren B; Stolz E; Michel MF
Sex Transm Dis; 1982; 9(4):200-1. PubMed ID: 6821501
[TBL] [Abstract][Full Text] [Related]
51. Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis.
Ito S; Yasuda M; Hatazaki K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M; Deguchi T
J Antimicrob Chemother; 2016 Sep; 71(9):2559-62. PubMed ID: 27246232
[TBL] [Abstract][Full Text] [Related]
52. Detection and analysis of two cases of the internationally spreading ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China.
Yang F; Zhang H; Chen Y; Zhai Y; Zhao F; Yu Y; van der Veen S
J Antimicrob Chemother; 2019 Dec; 74(12):3635-3636. PubMed ID: 31504585
[No Abstract] [Full Text] [Related]
53. [Bacteriological and clinical evaluation of the effect of azthreonam on gonorrheal urethritis in man].
Okazaki T
Jpn J Antibiot; 1984 Oct; 37(10):1773-9. PubMed ID: 6438364
[TBL] [Abstract][Full Text] [Related]
54. Present pattern of antibiotic sensitivity of gonococcal strains isolated in Bombay.
Moses JM; Desai MS; Bhosle CB; Trasi MS
Br J Vener Dis; 1971 Aug; 47(4):273-8. PubMed ID: 4998965
[No Abstract] [Full Text] [Related]
55. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of pefloxacin in acute gonococcal urethritis.
Bakare RA; Oni AA; Arowojolu AO; Okesola AO; Ayuba TT; Kehinde AO; Shomuyiwa T
Afr J Med Med Sci; 1997; 26(3-4):185-6. PubMed ID: 10456167
[TBL] [Abstract][Full Text] [Related]
57. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Harry TC
Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
[No Abstract] [Full Text] [Related]
58. Gonococcal inflammation of paraurethral glands around the external urethral orifice in males: a commonly encountered disease?
Fan W
Int J STD AIDS; 2010 Mar; 21(3):225-6. PubMed ID: 20071443
[No Abstract] [Full Text] [Related]
59. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
[TBL] [Abstract][Full Text] [Related]
60. Treatment of venereal diseases. I. Gonorrhea.
Farrar WE
Semin Drug Treat; 1972; 2(3):275-88. PubMed ID: 4282180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
